8-K: Diversified Healthcare Trust Revamps Senior Living Management, Boosts Outlook

Sentiment:

Investor Presentation and Strategic Update


Diversified Healthcare Trust announces a strategic shift in its senior living management, transitioning 116 communities to new operators and expecting significant financial and operational benefits.

Capital raiseDHC expects to receive $25 million to $40 million in net proceeds from monetizing its 34% ownership stake in AlerisLife, which will be used to reduce leverage and for general business purposes, including reinvestment.The company closed a new $150 million secured revolving credit facility in April 2025, currently undrawn, providing enhanced liquidity.DHC secured approximately $343 million in proceeds from secured financings in 2025 YTD at an average interest rate of 6.54%.The company's refinancing strategy includes addressing debt maturities with potential additional debt and asset sales.A stated risk factor is DHC's ability to effectively raise and balance its use of debt and equity capital.
Better than expectedLeverage improved from 11.2x in 4Q24 to 8.7x in 2Q25, with a target of 6.5x to 7.5x.Moody's upgraded DHC's credit rating to Caa3 in August 2025.Same property Cash Basis NOI increased by 11.2% year-over-year in 2Q25.SHOP same property NOI increased 18.5% year-over-year, driven by occupancy and rate increases.Medical Office and Life Science leasing activity achieved 11.5% higher rents than prior rents.The strategic transaction with AlerisLife is expected to yield $25 million to $40 million in net proceeds and enhance SHOP segment performance through diversified operators and operational efficiencies.Increased 2025 SHOP NOI outlook by $10 million at the midpoint and decreased total CapEx by $10 million.

Summary

  • Diversified Healthcare Trust (DHC) is transitioning management agreements for 116 senior living communities from AlerisLife Inc. to seven new operators.
  • This move is part of AlerisLife's complete asset sale and wind-down, which is expected to be completed by the first half of 2026.
  • DHC anticipates receiving $25 million to $40 million in net proceeds from monetizing its 34% ownership stake in AlerisLife.
  • The company reported a 2Q25 net loss of $91.6 million ($0.38 per share) and Normalized FFO of $18.6 million ($0.08 per share).
  • Same property Cash Basis NOI increased by 11.2% year-over-year to $71.2 million in 2Q25.
  • SHOP same property NOI grew 18.5% year-over-year, driven by a 100 basis point occupancy increase and 5.2% average monthly rate increase.
  • 2025 guidance includes year-end SHOP occupancy of 82-83%, an increased SHOP NOI outlook by $10 million at the midpoint, and a decreased total CapEx by $10 million.
  • Estimated disposition proceeds for 2025 are $635 million to $645 million, with $349 million completed year-to-date and $290 million under agreement or letters of intent.
  • DHC improved its leverage from 11.2x in 4Q24 to 8.7x in 2Q25 and received a Caa3 upgrade from Moody's in August 2025.

Sentiment

Score: 8

Explanation: The filing outlines significant strategic actions to improve operational performance and financial health, including a major management transition, successful capital recycling, and deleveraging efforts. While a net loss was reported, key operational metrics and future guidance are positive, and the Moody's upgrade indicates improving credit perception. The expected proceeds from AlerisLife and the focus on high-growth segments contribute to a strong positive outlook.

Positives

  • The strategic transition of 116 senior living communities to seven new operators is expected to diversify DHC's operator base, unlock operational efficiencies, drive cost savings, and accelerate revenue and NOI growth.
  • Expected net proceeds of $25 million to $40 million from AlerisLife's wind-down will be used to reduce leverage and for reinvestment.
  • Strong 2Q25 same property Cash Basis NOI growth of 11.2% year-over-year, reaching $71.2 million.
  • SHOP same property NOI increased 18.5% year-over-year, reflecting a 100 basis point increase in occupancy and a 5.2% increase in average monthly rate.
  • Medical Office and Life Science portfolio executed 106,000 square feet of leasing activity at weighted average rents 11.5% higher than prior rents.
  • Improved leverage from 11.2x in 4Q24 to 8.7x in 2Q25, with a target of 6.5x to 7.5x.
  • Moody's upgraded DHC's rating to Caa3 in August 2025.
  • Significant capital recycling with $349 million in dispositions completed year-to-date and an additional $290 million under agreement, contributing to debt reduction.
  • Favorable senior living industry trends, including 80+ population growth at a 4.0% CAGR over 15 years and depressed inventory growth at 1.0%.
  • Successful SHOP renovation case studies showing high ROI, such as Barrington Terrace with 128.6% ROI.
  • Strong medical office market tailwinds driven by an aging population, increased healthcare spending, and migration to outpatient care.
  • Life science sector maintaining fundamentals with high R&D spending, new drug applications, and drug approvals.
  • DHC's return on investment in AlerisLife is projected to be between 1.93x and 2.90x.

Negatives

  • Reported a net loss of $91.6 million, or $0.38 per share, in 2Q25.
  • The company's leverage ratio, while improved, is still at 8.7x, above its target range of 6.5x to 7.5x.
  • The 116 communities transitioning from AlerisLife have an occupancy of 81.4%, which is below the NIC benchmark of 88.3% for comparable markets, indicating a performance gap.
  • The 13 communities transitioned in April/May 2024 currently show a negative NOI of ($0.3) million, although stabilization is expected in 24-30 months.

Risks

  • Impact of unfavorable market and commercial real estate industry conditions due to possible reduced demand for healthcare related space and senior living communities, uncertainties surrounding interest rates, wage and commodity price inflation, supply chain disruptions, volatility in public debt and equity markets, pandemics, geopolitical instability, economic uncertainties, and labor market conditions.
  • Senior living operators' abilities to successfully and profitably operate the communities they manage for DHC.
  • The continuing impact of changing market practices on DHC and its managers and other operators and tenants, such as delayed recovery of the senior living industry, reduced demand for leased medical office, life science and other space, and increased operating costs.
  • The financial strength of DHC's managers and other operators and tenants.
  • Whether DHC's tenants will renew or extend their leases or whether DHC will obtain replacement tenants on terms as favorable as prior leases.
  • DHC's managers' abilities to increase or maintain rates charged to residents of DHC's senior living communities and manage operating costs.
  • DHC's ability to increase or maintain occupancy at its properties on desirable terms.
  • Risks and uncertainties regarding the costs and timing of development, redevelopment, and repositioning activities, including as a result of inflation, cost overruns, supply chain challenges, labor shortages, construction delays, or volatility in commercial real estate markets.
  • DHC's ability to manage its capital expenditures and other operating costs effectively and to maintain and enhance its properties.
  • DHC's ability to effectively raise and balance its use of debt and equity capital, and to comply with the financial covenants under its debt agreements.
  • DHC's ability to make required payments on its debt and maintain sufficient liquidity.
  • DHC's ability to sell properties at targeted prices or returns, and the timing of such sales.
  • Non-performance by counterparties to DHC's interest rate caps.
  • DHC's ability to pay distributions to its shareholders and to maintain its qualification for taxation as a REIT.
  • Competition in the real estate industry, particularly in those markets where DHC's properties are located.
  • Government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements.
  • Exposure to litigation and regulatory and government proceedings due to the nature of the senior living and other health and wellness related service businesses.
  • Actual and potential conflicts of interest with DHC's related parties, including its Managing Trustees, The RMR Group LLC, ABP Trust, AlerisLife Inc., and others affiliated with them.
  • Limitations imposed by and DHC's ability to satisfy complex rules to maintain its qualification for taxation as a REIT for U.S. federal income tax purposes.
  • Acts of terrorism, outbreaks of pandemics or other public health safety events or conditions, war or other hostilities, global climate change, or other manmade or natural disasters beyond DHC's control.
  • The closings of the sales of the management agreements are subject to customary closing conditions and lender and regulatory approvals, and these transactions may not close on the contemplated terms or at all or they may be delayed.
  • AlerisLife may not be able to complete the full wind-down of its business and operations on the contemplated terms or timeline or at all, which could impact DHC's expected proceeds.
  • DHC may not achieve the expected benefits from these transactions or may incur losses on the transactions.

Future Outlook

DHC anticipates continued outsized growth in its Senior Housing Operating Portfolio (SHOP) driven by strategic initiatives, including operator transitions, targeted sales and marketing, and expense control. The company projects year-end SHOP occupancy to grow to 82-83% and has increased its SHOP NOI outlook by $10 million at the midpoint for 2025. DHC expects to further improve its balance sheet by reducing leverage to a target of 6.5x to 7.5x through ongoing capital recycling and the proceeds from the AlerisLife wind-down. Favorable long-term healthcare sector tailwinds, including an aging U.S. population and strong demand for medical office and life science properties, are expected to support sustained growth.

Management Comments

  • Chris Bilotto, President and CEO of DHC: "Executing on these transactions marks an important milestone in being able to optimize our SHOP segment performance. By expanding our base of high-quality operators, improving concentration in key markets and partnering with groups that are making meaningful investments for our management agreements, we expect to enhance performance in our SHOP segment and increase returns for our shareholders."
  • Chris Bilotto: "These transactions are also expected to allow us to build on the momentum from the improved performance of the Five Star managed communities over the past few years, further strengthen our asset base and drive enhanced NOI growth across our SHOP communities."
  • Chris Bilotto: "We extend our gratitude to the AlerisLife team members, under the leadership of Jeff Leer, for the remarkable accomplishments achieved over the past several years. The teams dedication and focus have been the driving force behind the improved performance of the Five Star managed communities, enabling us to create lasting value."

Industry Context

The strategic shift in DHC's senior living management aligns with broader industry trends emphasizing specialized, regionalized operational expertise to drive performance in a competitive and evolving senior care market. The continued strong demand for medical office and life science properties, fueled by an aging population and advancements in healthcare, positions DHC favorably within the healthcare real estate sector. The company's focus on capital recycling and deleveraging reflects a common strategy among REITs to optimize portfolios and strengthen financial positions amidst fluctuating interest rates and economic uncertainties.

Comparison to Industry Standards

  • The 116 communities transitioning from AlerisLife have a 2Q25 occupancy of 81.4% and RevPOR of $5,043, which is below the NIC Benchmark for comparable markets of 88.3% occupancy and $5,244 RevPOR, indicating significant embedded upside potential for the new operators.
  • DHC's SHOP segment absorption rate of 3.3% in primary/secondary markets is comparable to the NIC Primary and Secondary benchmark of 3.5%, signaling strong supply/demand fundamentals.
  • SHOP RevPOR increased 5.4% year-over-year, outpacing the respective NIC markets' growth of +4.2% year-over-year, demonstrating DHC's ability to drive revenue per occupied room.
  • The projected 80+ population growth at a 4.0% CAGR over the next 15 years significantly outpaces the expected senior living inventory growth of 1.0%, aligning with favorable demographic trends that support DHC's long-term growth strategy.
  • DHC's medical outpatient same property NOI growth of 4.6% quarter-over-quarter and 2.2% year-over-year reflects a healthy performance in line with the growing demand for outpatient services, which saw utilization increase 31% from 2000 to 2023, while hospital inpatient admissions declined 19%.

Legal Proceedings

  • Exposure to litigation and regulatory and government proceedings due to the nature of the senior living and other health and wellness related service businesses.

Related Party Transactions

  • DHC is managed by The RMR Group LLC, an alternative asset manager, with management fees tied to DHC's share price performance and incentive fees contingent on total shareholder return outperformance.
  • Actual and potential conflicts of interest exist with DHC's related parties, including its Managing Trustees, The RMR Group LLC, ABP Trust, AlerisLife Inc., and others affiliated with them.
  • DHC owns a 34% interest in AlerisLife Inc., which is selling its assets and winding down, with DHC expecting to receive net proceeds from this monetization.

Stakeholder Impact

  • Shareholders are expected to benefit from enhanced SHOP segment performance, increased returns, reduced leverage, and potential for improved cost of capital. The monetization of AlerisLife stake is expected to be accretive.
  • Employees of AlerisLife Inc. will be impacted by the company's wind-down, implying job losses.
  • Residents of the senior living communities may experience improved operational efficiencies and care quality due to the transition to new operators.
  • The seven new operators are making strategic investments to purchase management agreements, aligning their interests with DHC and providing new business opportunities.
  • Creditors are positively impacted by DHC's debt reduction efforts, improved leverage ratio, and the Moody's credit rating upgrade.

Next Steps

  • Transition management agreements for 116 DHC senior living communities to seven new operators, beginning in September 2025 and expected to be completed by year-end.
  • AlerisLife Inc. to complete the sale of all its assets and wind-down its business by the first half of 2026.
  • DHC plans to use the net proceeds from AlerisLife's wind-down to reduce leverage and for general business purposes, including reinvestment in its SHOP segment.
  • Continue capital recycling plans, including the sale of 51 properties currently under agreement or letters of intent for expected gross proceeds of $290 million.
  • Focus on operational improvement initiatives within the SHOP portfolio, including personalized care plans, workflow automation, enhanced lead tracking, and revenue management.
  • Implement occupancy growth strategies, such as targeted sales and marketing, building referral partnerships, and expanding care options.
  • Target a leverage ratio of 6.5x to 7.5x to further enhance its cost of capital and improve its outlook with rating agencies.
  • Potentially exercise the one-time option to extend the maturity date of its 2026 zero coupon senior secured notes by one year.

Key Dates

DateDescription
2018Senior living inventory growth began decreasing.
2021New operator assumed operations of 17 legacy communities, leading to occupancy improvements and RevPOR growth.
2024-01-01Start of period for same property definition for six months ended June 30, 2025.
2024-04-01Start of period for same property definition for three months ended June 30, 2025.
2024-04-01Transition of 13 communities to an existing operator began.
2024-05-31Transition of 13 communities to an existing operator completed.
2024-12-31Green building certifications as of this date.
2025-03-311Q25 Life Science & SHOP Asset Sales completed, including $159 million sale of MUSE and $135 million sale of 18 triple-net leased senior living communities.
2025-04-25Closed $150 million secured revolving credit facility.
2025-05-29Closed $140 million mortgage financing.
2025-05-30Closed $109 million mortgage financing.
2025-06-11Closed $94 million of mortgage financings.
2025-06-30End of second quarter for financial results and portfolio data.
2025-08-04DHC's earnings publication date.
2025-08-12Moody's upgraded DHC to Caa3.
2025-08-25Date used for 12-month RevPOR and occupancy change calculations for renovation case studies.
2025-09-02YTD completed disposition proceeds as of this date.
2025-09-03Date of report, investor presentation, and press release; announcement of AlerisLife transaction.
2025-09-30Expected start of management agreement transitions for 116 DHC communities.
2025-12-31Expected completion of management agreement transitions for 116 DHC communities.
2026-06-30Expected completion of AlerisLife's full wind-down of business and operations.
2026-09-03Maturity date for $643.3 million in senior secured notes, with a one-time option to extend by one year.

Recommendation

buy

The strategic divestiture of AlerisLife management agreements and the transition to a diversified operator base are transformative for DHC's SHOP segment, promising enhanced operational efficiencies and NOI growth. The company's aggressive capital recycling and deleveraging efforts, evidenced by the improved leverage ratio and Moody's upgrade, significantly strengthen its financial position. With favorable demographic trends in senior living and robust fundamentals in medical office and life science sectors, DHC is well-positioned for long-term value creation. The embedded upside in the transitioning SHOP portfolio and the focus on ROI-driven capital expenditures further support a positive investment thesis.

Keywords

Healthcare REIT, Senior Living, Medical Office, Life Science, Real Estate, AlerisLife, Property Management, Capital Recycling, Debt Reduction, Occupancy Growth, NOI Growth, REIT, Diversified Healthcare Trust

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.